"Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Doravirine
Related studies linked through entity extraction aliases.
Doravirine Dose Optimisation in Pregnancy
- Status
- RECRUITING
- Phase
- PHASE4
HIV A6 Genome In ART Unsuccessful Patients On DOR
- Status
- UNKNOWN
- Phase
- N/A
Non-Interventional Observational Retrospective Study to Evaluate Doravirine Based-regimens in HIV Infected Aged Patients (DORAge).
- Status
- UNKNOWN
- Phase
- N/A
Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
- Status
- RECRUITING
- Phase
- PHASE3
Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD)
- Status
- COMPLETED
- Phase
- PHASE4
Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance
- Status
- COMPLETED
- Phase
- N/A
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Status
- RECRUITING
- Phase
- PHASE2
HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance
- Status
- UNKNOWN
- Phase
- PHASE4
Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
- Status
- COMPLETED
- Phase
- PHASE2
Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Pharmacokinetics of Doravirine (MK-1439) in Participants With Severe Renal Impairment (MK-1439-051)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Doravirine (MK-1439) (MK-1439-019)
- Status
- COMPLETED
- Phase
- PHASE1
A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005)
- Status
- COMPLETED
- Phase
- PHASE1